Table 2 AON and ERC immunostaining levels in NCI, MCI and AD
Region of interest | Clinical Diagnosis |  | Active Casp6 | TauΔCasp6 | PHF-1 | Aβ |
|---|---|---|---|---|---|---|
AON | NCI | Median | 837.7 | 472.9 | 3655.9 | 403.3 |
IQR | 289.0–1481.8 | 263.0–4182.6 | 1248.2–23248.5 | 109.9–658.2 | ||
n | 11 | 11 | 11 | 10 | ||
MCI | Median | 226.1 | 980.7 | 7494.4 | 452.9 | |
IQR | 118.1–2705.2 | 458.0–9493.4 | 651.1–67082.5 | 136.3–2993.1 | ||
n | 6 | 6 | 7 | 7 | ||
AD | Median | 23982.4 | 20400.0 | 75146.7 | 27355.0 | |
IQR | 11445.0–26221.2 | 3087.2–54521.9 | 41473.2–151857.4 | 1222.9–55633.7 | ||
n | 4 | 4 | 5 | 5 | ||
ERC | NCI | Median | 69.7 | 29.3 | 4138.2 | 940.7 |
IQR | 53.8–518.3 | 10.8–1138.3 | 615.9–16672.1 | 106.5–3406.6 | ||
n | 8 | 9 | 9 | 9 | ||
MCI | Median | 662.4 | 1035.8 | 15562.1 | 96.1 | |
IQR | 14.4–1639.4 | 246.8–3901.1 | 9394.8–42729.6 | 54.2–4787.4 | ||
n | 7 | 7 | 7 | 7 | ||
AD | Median | 1022.1 | 7859.5 | 56051.4 | 14342.6 | |
IQR | 497.2–1453.1 | 3181.4–18251.4 | 53590.7–70360.4 | 11159.6–24689.1 | ||
n | 4 | 5 | 3 | 5 |